wwwPosted Jul 8th 2008 11:00AM by Paul Foster
Filed under: Options
Cardiome Pharma (NASDAQ: CRME) closed at $8.66 Monday.
Phase 2b data is expected soon for a oral formulation of Kynapid (vernakalant), a drug to restore normal heart rhythm in patients with arterial fibrillation.
CRME July option implied volatility of 195 is above its 26-week average of 131 according to Track Data, suggesting larger price movement.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
| # | Blogger | Posts | Cmts |
|---|---|---|---|
| 1 | Joseph Lazzaro | 107 | 0 |
| 2 | Tom Johansmeyer | 97 | 3 |
| 3 | Connie Madon | 50 | 0 |
| 4 | Steven Mallas | 43 | 0 |
| 5 | Mark Fightmaster | 41 | 0 |
| 6 | Tom Taulli | 40 | 0 |
| 7 | Steven Halpern | 31 | 0 |
| 8 | Trey Thoelcke | 29 | 0 |
| 9 | Melly Alazraki | 26 | 0 |
| 10 | Zac Bissonnette | 24 | 0 |
| 11 | Paul Foster | 24 | 0 |
| 12 | Brian White | 22 | 0 |
| 13 | Brent Archer | 21 | 0 |
| 14 | Jon Ogg | 21 | 0 |
| 15 | Jim Cramer | 21 | 0 |
| 16 | Elizabeth Harrow | 18 | 0 |
| 17 | Eric Buscemi | 17 | 0 |
| 18 | Sheldon Liber | 13 | 0 |
| 19 | Michael Fowlkes | 8 | 0 |
| 20 | Beth Gaston Moon | 8 | 0 |
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
Other Weblogs Inc. Network blogs you might be interested in:
Before the bell: Futures sharply lower on Dubai's debt problems
Will Rich Ross really have a positive impact on Disney's movie operations?
Consumers sick of recession, may spend extra on holidays
